The Joint Corp. (JYNT) Q1 2026 Earnings Call Transcript
The Joint Corp. 2026 Q1 - Results - Earnings Call Presentation
Joint Q1 EPS $0.08 Beats $0.03 Estimate, Sales $14.820M Beat $14.502M Estimate
The Joint Strikes Asset Purchase Agreement To Divest 45 Corporate Managed Clinics In Southern California For ~$2.3M To Elite Chiro Group
The Joint Corp. 2025 Q4 - Results - Earnings Call Presentation
The Joint Corp. (JYNT) Q4 2025 Earnings Call Transcript
CORRECTION: Joint Q4 EPS $0.06 Misses $0.09 Estimate, Sales $15.167M Beat $14.492M Estimate
The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast
The Joint Corp. (NASDAQ:JYNT) is definitely on the radar of institutional investors who own 42% of the company
Estimating The Intrinsic Value Of The Joint Corp. (NASDAQ:JYNT)
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
Joint (NASDAQ:JYNT) Has Some Difficulty Using Its Capital Effectively
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
The Joint Corp. Signs $1.5M APA To Sell 22 Clinics, Buyers Assume Operations Mid‑December; Terminates Prior 45‑Clinic Southern California Deal
Bullish Joint Insiders Loaded Up On US$509.3k Of Stock
Are Options Traders Betting on a Big Move in The Joint Stock?
Is Now The Time To Look At Buying The Joint Corp. (NASDAQ:JYNT)?
The Joint Corp. (JYNT) Q3 2025 Earnings Call Transcript
The Joint Corp (JYNT) Q3 2025 Earnings Call Highlights: Strategic Refranchising and Revenue ...
The Joint Corp. Reports Third Quarter 2025 Financial Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.